Johnson & Johnson (JNJ) earnings Q1 2023


Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street’s expectations, but lowered its sales guidance for its pharmaceutical business.

J&J, whose financial results are considered a bellwether for many health companies, said its sales during the quarter grew 5.6% over the same quarter last year. 

The consumer staples giant reported a net loss of $68 million, or 3 cents per share, related to its talc baby powder liabilities and costs tied to the upcoming spinoff of its consumer health business. That compares with a net income of $5.2 billion, or $1.93 per share, for the same period a year ago. Excluding certain items, adjusted…

Source cnbc.com

0 0 votes
Article Rating

United Airlines (UAL) earnings Q1 2023

Previous article

Mortgage demand from homebuyers drops 10% as interest rates jump

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings